Efficacy and tolerability of PTK787/ZK 222584 in a phase II study of post-transplant maintenance therapy in patients with multiple myeloma following high-dose chemotherapy and autologous stem cell transplant

Ravi Vij; George Ansstas; James C. Mosley; George Bryant; Anjum Hassan; Catalina Amador-Ortiz; Elizabeth Procknow

doi:10.3109/10428194.2010.488709

Efficacy and tolerability of PTK787/ZK 222584 in a phase II study of post-transplant maintenance therapy in patients with multiple myeloma following high-dose chemotherapy and autologous stem cell transplant

Ravi Vij, George Ansstas, James C. Mosley, George Bryant, Anjum Hassan, Catalina Amador-Ortiz, Elizabeth Procknow

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1577-1579
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	51
Issue number	8
DOIs	https://doi.org/10.3109/10428194.2010.488709
State	Published - Aug 2010

Access to Document

10.3109/10428194.2010.488709

Cite this

Vij, R., Ansstas, G., Mosley, J. C., Bryant, G., Hassan, A., Amador-Ortiz, C., & Procknow, E. (2010). Efficacy and tolerability of PTK787/ZK 222584 in a phase II study of post-transplant maintenance therapy in patients with multiple myeloma following high-dose chemotherapy and autologous stem cell transplant. Leukemia and Lymphoma, 51(8), 1577-1579. https://doi.org/10.3109/10428194.2010.488709

@article{1a8f2c509c0d40aaaf07148ee1f09385,

title = "Efficacy and tolerability of PTK787/ZK 222584 in a phase II study of post-transplant maintenance therapy in patients with multiple myeloma following high-dose chemotherapy and autologous stem cell transplant",

author = "Ravi Vij and George Ansstas and Mosley, {James C.} and George Bryant and Anjum Hassan and Catalina Amador-Ortiz and Elizabeth Procknow",

year = "2010",

month = aug,

doi = "10.3109/10428194.2010.488709",

language = "English",

volume = "51",

pages = "1577--1579",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

number = "8",

}

Vij, R , Ansstas, G, Mosley, JC, Bryant, G, Hassan, A, Amador-Ortiz, C & Procknow, E 2010, 'Efficacy and tolerability of PTK787/ZK 222584 in a phase II study of post-transplant maintenance therapy in patients with multiple myeloma following high-dose chemotherapy and autologous stem cell transplant', Leukemia and Lymphoma, vol. 51, no. 8, pp. 1577-1579. https://doi.org/10.3109/10428194.2010.488709

Efficacy and tolerability of PTK787/ZK 222584 in a phase II study of post-transplant maintenance therapy in patients with multiple myeloma following high-dose chemotherapy and autologous stem cell transplant. / Vij, Ravi ; Ansstas, George; Mosley, James C. et al.
In: Leukemia and Lymphoma, Vol. 51, No. 8, 08.2010, p. 1577-1579.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Efficacy and tolerability of PTK787/ZK 222584 in a phase II study of post-transplant maintenance therapy in patients with multiple myeloma following high-dose chemotherapy and autologous stem cell transplant

AU - Vij, Ravi

AU - Ansstas, George

AU - Mosley, James C.

AU - Bryant, George

AU - Hassan, Anjum

AU - Amador-Ortiz, Catalina

AU - Procknow, Elizabeth

PY - 2010/8

Y1 - 2010/8

UR - http://www.scopus.com/inward/record.url?scp=77955433927&partnerID=8YFLogxK

U2 - 10.3109/10428194.2010.488709

DO - 10.3109/10428194.2010.488709

M3 - Letter

C2 - 20528249

AN - SCOPUS:77955433927

SN - 1042-8194

VL - 51

SP - 1577

EP - 1579

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 8

ER -

Efficacy and tolerability of PTK787/ZK 222584 in a phase II study of post-transplant maintenance therapy in patients with multiple myeloma following high-dose chemotherapy and autologous stem cell transplant

Access to Document

Other files and links

Cite this